Third Harmonic Bio, Inc

Third Harmonic Bio, Inc is a biopharmaceutical company based in San Francisco, CA, dedicated to advancing the next generation of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases. With a focus on developing novel therapeutics, their lead product candidate, THB335, is expected to enter clinical trials in the first half of 2024, aiming to provide broad symptomatic relief across a range of inflammatory disorders through KIT inhibition of mast cells.

Driven by their purpose to improve the lives of patients, Third Harmonic Bio seeks passionate individuals who are big picture thinkers and committed to making a difference in the field of medicine. With a strong emphasis on scientific research and development, they are determined to build a great company that revolutionizes the treatment of inflammatory diseases.

Generated from the website